Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China flag China · Delayed Price · Currency is CNY
25.54
-0.05 (-0.20%)
Feb 3, 2026, 11:29 AM CST

SHA:600566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
5,1306,6697,7384,8193,8192,959
Trading Asset Securities
5,8045,1613,1783,0451,6751,258
Cash & Short-Term Investments
10,93411,83010,9167,8635,4944,217
Cash Growth
-6.56%8.37%38.82%43.13%30.28%70.40%
Accounts Receivable
1,5752,2572,7822,8502,1832,032
Other Receivables
31.512.514.9917.211.9810.33
Receivables
1,6072,2702,7972,8672,1952,042
Inventory
344.74569.09490.08391.48375.59278.42
Other Current Assets
59.9532.632.554.2358.3438.13
Total Current Assets
12,94514,70214,23511,1778,1236,576
Property, Plant & Equipment
2,5122,7062,9222,8563,0343,141
Long-Term Investments
487.39464.71393.97332.34328.44155.33
Goodwill
167.3167.3167.3167.3167.3167.3
Other Intangible Assets
337.98308.56305.01320.62280.04283.84
Long-Term Deferred Tax Assets
35.5341.8345.4562.1657.3242.62
Long-Term Deferred Charges
5.782.3811.913.8713.1923.67
Other Long-Term Assets
41.6466.4462.1662.14127.96126.51
Total Assets
16,53418,45918,14414,98112,13110,516
Accounts Payable
1,0801,7302,1411,505945.77452.52
Accrued Expenses
99.59254.87246.62350.39242.7207.74
Short-Term Debt
648.1836.391,088400--
Current Portion of Long-Term Debt
----627.55-
Current Portion of Leases
40.151.071.060.441.55-
Current Income Taxes Payable
152.0499.77182.62106.0943.7169.64
Current Unearned Revenue
17.6817.9217.2549.1419.348.03
Other Current Liabilities
393.89598.01915.861,016919.981,229
Total Current Liabilities
2,4323,5384,5923,4272,8011,967
Long-Term Debt
37.18----602.58
Long-Term Leases
0.611.041.430.21.02-
Long-Term Unearned Revenue
60.7865.4571.4378.1984.6390.67
Long-Term Deferred Tax Liabilities
145.08127.84109.28122.05112.3890.72
Other Long-Term Liabilities
0.440.530.821.061.351.67
Total Liabilities
2,6763,7334,7753,6293,0002,753
Common Stock
452.17452.69452.74452.74436.27436.26
Additional Paid-In Capital
3,9994,0123,9993,9843,1483,114
Retained Earnings
9,44810,3459,0106,9985,4314,112
Treasury Stock
-69.18-108.57-111.97-97.18--
Comprehensive Income & Other
----100.81100.87
Total Common Equity
13,82914,70213,34911,3379,1177,763
Minority Interest
28.3524.5719.4215.1414.17-
Shareholders' Equity
13,85814,72613,36911,3529,1317,763
Total Liabilities & Equity
16,53418,45918,14414,98112,13110,516
Total Debt
726.04838.51,090400.65630.12602.58
Net Cash (Debt)
10,20810,9929,8267,4634,8643,615
Net Cash Growth
-2.55%11.86%31.67%53.43%34.56%90.37%
Net Cash Per Share
11.1111.9810.728.225.404.33
Filing Date Shares Outstanding
906.07912.53921.81921.82888.27888.26
Total Common Shares Outstanding
906.07912.53921.81921.82888.27888.26
Working Capital
10,51411,1649,6447,7495,3224,609
Book Value Per Share
15.2616.1114.4812.3010.268.74
Tangible Book Value
13,32414,22612,87710,8498,6707,312
Tangible Book Value Per Share
14.7115.5913.9711.779.768.23
Buildings
-2,9532,9112,4552,4732,362
Machinery
-1,7281,6851,6441,5661,488
Construction In Progress
-156.63186.98352.15322.17364.89
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.